Table 4: Cancer incidence Taranto NPCS. Number of observed cases (Obs), standardized incidence ratio crude (SIR); 90% IC: 90% confidence interval; Reference SIR: macroarea South and Islands 2005–2007; Reference SIR: Taranto province excluding NPCS municipalities (TA-NPCS) 2006-2007.

Cancer siteMalesFemales
OBSSIR-macroarea South and Islands
(90% CI)
SIR (TA-NPCS)
(90% CI)
OBSSIR-macro-area South and Islands
(90% CI)
SIR (TA-NPCS) (90% CI)

Head and neck5298 (77–123)131 (103–165)1396 (57–153)134 (79–213)
Stomach51130 (102–164)117 (91–148)43167 (127–215)224 (171–289)
Colon and rectum145112 (97–129)122 (106–140)131115 (99–133)121 (104–140)
Liver64110 (88–135)140 (113–172)36110 (82–145)175 (130–231)
Pancreas28100 (71–137)135 (96–185)31113 (82–153)129 (93–174)
Lung245144 (129–160)150 (135–167)47117 (90–149)148 (114–189)
Skin melanoma35214 (158–284)193 (143–256)23143 (98–203)120 (82–170)
Mesothelioma21429 (287–618)256 (172–369)3197 (53–509)81 (22–209)
Breast317130 (118–143)124 (113–136)
Prostate204129 (112–148)121 (105–139)
Testis12109 (63–177)79 (46–128)
Uterus, cervix1493 (56–145)88 (53–138)
Uterus, body69134 (109–164)188 (152–230)
Ovary35119 (88–158)81 (60–107)
Kidney and other unspecified urinary organs51164 (128–207)201 (157–254)18119 (77–176)114 (74–169)
Bladder188141 (125–159)136 (120–153)2362 (42–88)92 (63–130)
Brain and CNS (malignant)1686 (54–131)88 (55–134)1278 (45–126)65 (37–105)
Thyroid23169 (115–239)126 (86–179)71152 (124–185)94 (76–115)
Hodgkin lymphoma688 (38–174)63 (27–124)8131 (65–236)70 (35–126)
Non-Hodgkin lymphoma42119 (90–154)160 (122–207)2888 (63–121)143 (102–196)
Myeloma18140 (90–208)135 (87–200)15107 (66–165)97 (60–149)
Leukemia30108 (78–146)82 (59–111)37164 (122–216)103 (77–136)
All tumors excluding skin, nonmalignant brain, and CNS 1338131 (125–137)130 (124–136)1084126 (120–132)121 (115–127)